For whatever reason, the grownups seem to get all the attention when talk turns to AI in healthcare. All the kiddos get to do is look on and listen in. Now comes a worthy little effort to balance the seesaw.

It’s going to take a multinational effort for the global AI community—such as it is—to avoid the emergence of a “fragmented AI landscape.” 

The U.S. Food and Drug Administration has its hands full making sure medical AI products are safe, efficacious and trustworthy before they hit the market. The rise of ever-more-innovative iterations of the technology—not least generative AI—is only adding to the burden. 

The settlement also includes an agreement for operational changes at all of the insurer's 33 independent partners.

Among AI’s most watchful stakeholders are healthcare organizations in need of AI talent and AI talent in need of work in healthcare. Both groups need to keep up with the technology in its present as well as future iterations.

Dynocardia has now received nearly $5.1 million in funding from the NHLBI to help speed commercializing its wrist-worn monitor to avoid the need for invasive catheter BP monitoring.

Timothy Story, MD, said Ascension St. Vincent Medical Center damaged his career and reputation after they fired him without cause. After a three-and-a-half year legal trial, a jury in Indiana agreed. 

The 18th annual rankings of the nation's best children's hospitals has been released by U.S. News & World Report, highlighting the top places for young patients to receive exceptional care in 2024-2025.